# clm_76A176931199

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: total_equity  
value: 4,076,506,000 United States dollar  
valid_from: 2016-06-30  
valid_to: 2016-09-30  
published: 2016-08-04  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_BD93EEA985A9  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals total equity: 4,076,506,000 United States dollar", as of 2016-06-30 (until 2016-09-30). Claim clm_76A176931199, https://asof.is/claim/clm_76A176931199, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217616000067/0001532176-16-000067-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q2 FY2016, filed 2016-08-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217616000067/0001532176-16-000067-index.htm (primary, SEC EDGAR 10-Q Q2 FY2016, published 2016-08-04)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 3,765,082,000 United States dollar | valid 2016-03-31 to 2016-06-30 | conf 0.95 | superseded | superseded_by [clm_76A176931199](/claim/clm_76A176931199.md) | [clm_6F441A6B882E](/claim/clm_6F441A6B882E.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.